This study highlights distinct PD-L1 roles in ESCC’s tumoral and stromal areas, underlining the importance of understanding these mechanisms in the tumor immune microenvironment to develop better treatments and improve patient outcomes. The gene discussed is CD274; the disease is esophageal squamous cell carcinoma.